A detailed history of First Eagle Investment Management, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, First Eagle Investment Management, LLC holds 431,843 shares of AXGN stock, worth $10.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
431,843
Previous 177,955 142.67%
Holding current value
$10.2 Million
Previous $1.93 Million 299.17%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$10.77 - $17.84 $2.73 Million - $4.53 Million
253,888 Added 142.67%
431,843 $7.7 Million
Q2 2025

Aug 06, 2025

BUY
$9.29 - $17.81 $1.65 Million - $3.17 Million
177,955 New
177,955 $1.93 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $1B
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track First Eagle Investment Management, LLC Portfolio

Follow First Eagle Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Eagle Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Eagle Investment Management, LLC with notifications on news.